Early research (Phase 1)Study completedNCT02993055What this trial is testingAssess Ulimorelin in Healthy SubjectsWho this might be right forHealthy Subjects Lyric Pharmaceuticals 39
Early research (Phase 1)Study completedNCT01887626What this trial is testingStudy to Investigate if the Uptake of Ticagrelor Into the Body Differs Depending on Method of Administration.Who this might be right forBioavailability Heathy Volunteers AstraZeneca 36
Large-scale testing (Phase 3)Study completedNCT00639678What this trial is testingEvaluate the Safety and Tolerability of Raxibacumab in Healthy SubjectsWho this might be right forHealthy Human Genome Sciences Inc. 322
Early research (Phase 1)Looking for participantsNCT06786676What this trial is testingClinical Trial to Investigate the Safety, Tolerability, and Pharmacokinetics of AS-S603 in Healthy ParticipantsWho this might be right forHealthy Amyloid Solution Inc 88
Early research (Phase 1)Study completedNCT05099510What this trial is testingSafety and Pharmacokinetics (PK) Study of Natrunix in Healthy VolunteersWho this might be right forPharmacokinetics XBiotech, Inc. 24
Early research (Phase 1)Study completedNCT02018510What this trial is testingA Phase 1, Open Label, Dose-escalation Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 3BNC117Who this might be right forHealthyHIV Rockefeller University 49
Early research (Phase 1)UnknownNCT05499260What this trial is testingEvaluate the Safety, Tolerability, and Pharmacokinetics of CB03-154 in Healthy ParticipantsWho this might be right forHealthy Volunteers Shanghai Zhimeng Biopharma, Inc. 70
Early research (Phase 1)Study completedNCT00761540What this trial is testingTo Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or PlaceboWho this might be right forDiabetesHealthy Novo Nordisk A/S 37
Testing effectiveness (Phase 2)Study completedNCT01511250What this trial is testingStudy to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 YearsWho this might be right forHealthy Takeda 360
Early research (Phase 1)Study completedNCT03007810What this trial is testingSafety and Pharmacokinetics of Hemay005 In Healthy Male SubjectsWho this might be right forPsoriasis Tianjin Hemay Bio-Tech Co., Ltd 68
Early research (Phase 1)Study completedNCT05226923What this trial is testingStudy of the Safety and Pharmacokinetics of KSP-1007 Alone and Coadministered With Meropenem in Healthy SubjectsWho this might be right forBacterial Infections Sumitovant Biopharma, Inc. 123
Early research (Phase 1)Study completedNCT02340325What this trial is testingFS2 Safety and Tolerability Study in Healthy VolunteersWho this might be right forCicatrixCicatrix, HypertrophicKeloid British Columbia Professional Firefighters' Burn and Wound Healing Laboratory 20
Early research (Phase 1)Looking for participantsNCT07443059What this trial is testingZovaglutide (ZT002 Injection) in Participants With Impaired Kidney Function and Healthy ParticipantsWho this might be right forOverweight , Obesity Beijing QL Biopharmaceutical Co.,Ltd 40
Testing effectiveness (Phase 2)Study completedNCT01299480What this trial is testingA Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 YearsWho this might be right forMeningococcal Vaccine Pfizer 1,714
Early research (Phase 1)Study completedNCT04758234What this trial is testingLY3549492 in Healthy ParticipantsWho this might be right forHealthy Eli Lilly and Company 54
Very early researchStudy completedNCT06541093What this trial is testingStudy to Evaluate the Safety and Immunogenicity of an HIV-1 Vaccine Regimen of Adjuvanted UVAX-1107 Followed by Adjuvanted UVAX-1107 or Adjuvanted UVAX-1197 in Healthy Subjects Aged 25-55 Years.Who this might be right forAIDS/HIV - RelatedDisease Associated With AIDSVaccine-Preventable DiseasesHIV Infections Uvax Bio LLC 34
Early research (Phase 1)Study completedNCT04894071What this trial is testingQA102 Phase 1 Study in Healthy Young and Older Adult SubjectsWho this might be right forAge-related Macular Degeneration Smilebiotek Zhuhai Limited 69
Early research (Phase 1)Study completedNCT00938899What this trial is testingTMC435350-TiDP16-C101 - A Study to Examine the Safety, Tolerability and Pharmacokinetics of Increasing Oral Doses of TMC435350 After Single and Repeated DosingWho this might be right forHepatitis C Tibotec Pharmaceuticals, Ireland 55
Early research (Phase 1)Study completedNCT04015232What this trial is testingComparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.Who this might be right forImmunogenicityHealthy Volunteers Intas Pharmaceuticals, Ltd. 200
Early research (Phase 1)Study completedNCT02967159What this trial is testingEvaluate the Disposition of Drug in Body and Safety After Administration of Single Inhaled Doses of Drugs Abediterol and AZD7594 Administered Alone, in Fixed Dose Combination and in Free Combination Using the Dry Powder Inhaler in Healthy Male ParticipantsWho this might be right forChronic Obstructive Pulmonary Disease (COPD)Asthma AstraZeneca 14